BG107864A - Производни на заместени пиразинохиноксалини като агонисти и антагонисти на серотонинов рецептор - Google Patents
Производни на заместени пиразинохиноксалини като агонисти и антагонисти на серотонинов рецептор Download PDFInfo
- Publication number
- BG107864A BG107864A BG107864A BG10786403A BG107864A BG 107864 A BG107864 A BG 107864A BG 107864 A BG107864 A BG 107864A BG 10786403 A BG10786403 A BG 10786403A BG 107864 A BG107864 A BG 107864A
- Authority
- BG
- Bulgaria
- Prior art keywords
- phenyl
- substituted
- alkyl
- independently selected
- alkenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25676500P | 2000-12-20 | 2000-12-20 | |
| PCT/US2001/049374 WO2002059127A2 (en) | 2000-12-20 | 2001-12-19 | Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG107864A true BG107864A (bg) | 2004-03-31 |
Family
ID=22973498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG107864A BG107864A (bg) | 2000-12-20 | 2003-05-30 | Производни на заместени пиразинохиноксалини като агонисти и антагонисти на серотонинов рецептор |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6638934B2 (pt) |
| EP (1) | EP1345942B9 (pt) |
| JP (2) | JP4346307B2 (pt) |
| KR (1) | KR20030069192A (pt) |
| CN (1) | CN1505631A (pt) |
| AT (1) | ATE318819T1 (pt) |
| AU (1) | AU2002248216B2 (pt) |
| BG (1) | BG107864A (pt) |
| BR (1) | BR0116347A (pt) |
| CA (1) | CA2431970A1 (pt) |
| DE (1) | DE60117617T2 (pt) |
| EE (1) | EE200300301A (pt) |
| ES (1) | ES2260335T3 (pt) |
| HU (1) | HUP0303513A3 (pt) |
| IL (1) | IL156201A0 (pt) |
| IS (1) | IS6850A (pt) |
| MX (1) | MXPA03005437A (pt) |
| NO (1) | NO20032795L (pt) |
| PL (1) | PL366060A1 (pt) |
| RU (1) | RU2003121406A (pt) |
| SK (1) | SK7022003A3 (pt) |
| WO (1) | WO2002059127A2 (pt) |
| ZA (1) | ZA200304303B (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002059127A2 (en) * | 2000-12-20 | 2002-08-01 | Bristol-Myers Squibb Pharma Company | Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists |
| US7244843B2 (en) * | 2003-10-07 | 2007-07-17 | Bristol-Myers Squibb Company | Modulators of serotonin receptors |
| GB0417558D0 (en) * | 2004-08-06 | 2004-09-08 | Merck Sharp & Dohme | Novel combination therapy |
| EP2248524A3 (en) | 2004-08-25 | 2011-03-09 | Takeda Pharmaceutical Company Limited | Preventives/remedies for stress urinary incontinence and method of screening the same |
| EP2018863B9 (en) | 2006-05-16 | 2015-02-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
| EP2216023A4 (en) | 2007-11-15 | 2013-03-13 | Takeda Pharmaceutical | CONDENSED PYRIDINE DERIVATIVE AND USE THEREOF |
| US20120253036A1 (en) | 2009-12-11 | 2012-10-04 | Yukinori Nagakura | Agent for treating fibromyalgia |
| WO2012030953A1 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level |
| WO2014078568A1 (en) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
| WO2019131902A1 (ja) | 2017-12-27 | 2019-07-04 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4183936A (en) | 1972-06-19 | 1980-01-15 | Endo Laboratories, Inc. | Pyridopyrrolobenzheterocycles |
| US3914421A (en) | 1972-06-19 | 1975-10-21 | Endo Lab | Pyridopyrrolobenzheterocycles for combatting depression |
| US4238607A (en) | 1972-06-19 | 1980-12-09 | Endo Laboratories Inc. | Pyridopyrrolo benzheterocycles |
| US4115577A (en) | 1972-06-19 | 1978-09-19 | Endo Laboratories, Inc. | Pyridopyrrolobenzheterocycles |
| US4013652A (en) | 1972-06-19 | 1977-03-22 | Endo Laboratories, Inc. | Pyridopyrrolobenzoxazine |
| US4219550A (en) | 1978-11-09 | 1980-08-26 | E. I. Du Pont De Nemours And Company | Cis- and trans- octahydropyridopyrrolobenzheterocycles |
| HUT61548A (en) | 1990-08-27 | 1993-01-28 | Sandoz Ag | Process for producing indolonaphthyridine derivatives and pharmaceutical compositions comprising such compounds |
| JP2002532504A (ja) | 1998-12-17 | 2002-10-02 | アメリカン・ホーム・プロダクツ・コーポレイション | ５−ｈｔ２ｃ作動薬である２，３，４，４ａ−テトラヒドロ−１ｈ−ピラジノ（１，２−ａ）キノキサリン−５（６ｈ）−オン誘導体 |
| WO2002059127A2 (en) * | 2000-12-20 | 2002-08-01 | Bristol-Myers Squibb Pharma Company | Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists |
-
2001
- 2001-12-19 WO PCT/US2001/049374 patent/WO2002059127A2/en active IP Right Grant
- 2001-12-19 US US10/026,404 patent/US6638934B2/en not_active Expired - Lifetime
- 2001-12-19 PL PL01366060A patent/PL366060A1/xx not_active Application Discontinuation
- 2001-12-19 HU HU0303513A patent/HUP0303513A3/hu not_active Application Discontinuation
- 2001-12-19 MX MXPA03005437A patent/MXPA03005437A/es unknown
- 2001-12-19 ES ES01997097T patent/ES2260335T3/es not_active Expired - Lifetime
- 2001-12-19 JP JP2002559429A patent/JP4346307B2/ja not_active Expired - Fee Related
- 2001-12-19 EE EEP200300301A patent/EE200300301A/xx unknown
- 2001-12-19 CA CA002431970A patent/CA2431970A1/en not_active Abandoned
- 2001-12-19 CN CNA01822704XA patent/CN1505631A/zh active Pending
- 2001-12-19 BR BR0116347-7A patent/BR0116347A/pt not_active Application Discontinuation
- 2001-12-19 IL IL15620101A patent/IL156201A0/xx unknown
- 2001-12-19 AT AT01997097T patent/ATE318819T1/de active
- 2001-12-19 SK SK702-2003A patent/SK7022003A3/sk unknown
- 2001-12-19 RU RU2003121406/04A patent/RU2003121406A/ru not_active Application Discontinuation
- 2001-12-19 EP EP01997097A patent/EP1345942B9/en not_active Expired - Lifetime
- 2001-12-19 AU AU2002248216A patent/AU2002248216B2/en not_active Ceased
- 2001-12-19 KR KR10-2003-7008273A patent/KR20030069192A/ko not_active Application Discontinuation
- 2001-12-19 DE DE60117617T patent/DE60117617T2/de not_active Expired - Lifetime
-
2003
- 2003-05-30 BG BG107864A patent/BG107864A/bg unknown
- 2003-06-02 ZA ZA200304303A patent/ZA200304303B/en unknown
- 2003-06-18 IS IS6850A patent/IS6850A/is unknown
- 2003-06-19 NO NO20032795A patent/NO20032795L/no not_active Application Discontinuation
-
2009
- 2009-05-11 JP JP2009114360A patent/JP5117440B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO20032795D0 (no) | 2003-06-19 |
| US6638934B2 (en) | 2003-10-28 |
| CN1505631A (zh) | 2004-06-16 |
| RU2003121406A (ru) | 2004-12-27 |
| ZA200304303B (en) | 2004-09-02 |
| IS6850A (is) | 2003-06-18 |
| JP5117440B2 (ja) | 2013-01-16 |
| MXPA03005437A (es) | 2003-09-10 |
| EP1345942A2 (en) | 2003-09-24 |
| US20020177596A1 (en) | 2002-11-28 |
| EP1345942B1 (en) | 2006-03-01 |
| KR20030069192A (ko) | 2003-08-25 |
| DE60117617D1 (de) | 2006-04-27 |
| PL366060A1 (en) | 2005-01-24 |
| AU2002248216B2 (en) | 2007-03-01 |
| IL156201A0 (en) | 2003-12-23 |
| DE60117617T2 (de) | 2007-01-25 |
| HUP0303513A3 (en) | 2005-12-28 |
| WO2002059127A2 (en) | 2002-08-01 |
| NO20032795L (no) | 2003-08-04 |
| SK7022003A3 (en) | 2004-08-03 |
| JP2009215304A (ja) | 2009-09-24 |
| JP2004524298A (ja) | 2004-08-12 |
| CA2431970A1 (en) | 2002-08-01 |
| JP4346307B2 (ja) | 2009-10-21 |
| HUP0303513A2 (hu) | 2004-01-28 |
| EE200300301A (et) | 2003-10-15 |
| ATE318819T1 (de) | 2006-03-15 |
| BR0116347A (pt) | 2004-07-06 |
| ES2260335T3 (es) | 2006-11-01 |
| EP1345942B9 (en) | 2006-11-15 |
| WO2002059127A3 (en) | 2002-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1189905B1 (en) | Substituted heterocycle fused gamma-carbolines | |
| JP5117440B2 (ja) | セロトニン受容体アゴニストおよびアンタゴニストとしての置換されたピラジノキノキサリン誘導体 | |
| US7183282B2 (en) | Substituted heterocycle fused γ-carbolines | |
| AU2002246726B2 (en) | Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists | |
| KR20030070073A (ko) | 세로토닌 효능제 및 길항제로서의 치환된 피리도인돌 | |
| AU2002248216A1 (en) | Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists | |
| US6780862B2 (en) | Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands | |
| AU2002246725A1 (en) | Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |